**Question:** Which one of the following is not true regarding Centchroman?

A. Centchroman is a selective estrogen receptor modulator (SERM)
B. Centchroman is primarily used to treat endometriosis
C. Centchroman is used to prevent pregnancy
D. Centchroman has significant estrogenic effects

**Core Concept:**
Centchroman is a synthetic compound developed as a selective estrogen receptor modulator (SERM). SERMs are a class of drugs that act as agonists or antagonists at the estrogen receptor depending on the tissue. This characteristic allows SERMs to have estrogenic or anti-estrogenic effects in different tissues, thereby exploiting their dual action for therapeutic purposes.

**Why the Correct Answer is Right:**
Centchroman is primarily used for preventing pregnancy, which is a misconception in this case. SERMs like Centchroman are primarily developed to modulate the estrogen receptor action in specific tissues, rather than treating endometriosis (option B). While Centchroman does have estrogenic effects, it is not primarily used for endometrial protection, unlike tamoxifen (a different SERM used for that purpose).

**Why Each Wrong Option is Incorrect:**

**Option A:** Centchroman is a SERM, but it is not used for treating endometriosis (a condition primarily treated with tamoxifen).

**Option B:** Centchroman is primarily used for preventing pregnancy, not treating endometriosis.

**Option C:** Although Centchroman has estrogenic effects, its primary use is as a progestin in contraception, not for endometrial protection.

**Option D:** Centchroman has significant estrogenic effects, but its primary use is as a progestin in contraception, not for endometrial protection.

**Clinical Pearl:**
Centchroman is a progestin-only contraceptive pill (POP) used to prevent pregnancy. It works by suppressing the hypothalamic-pituitary-ovarian axis, thereby inhibiting ovulation and reducing the risk of pregnancy. Unlike estrogen-only contraceptives, Centchroman does not cause significant changes in the endometrium, making it a safer choice for women with a history of venous thromboembolism or those with contraindications to estrogen use.